META-ANALYSIS OF CYP2D6 METABOLIZER PHENOTYPE AND METOPROLOL PHARMACOKINETICS

Metoprolol, a commonly prescribed beta-blocker, is primarily metabolized by cytochrome P450 2D6 (CYP2D6), an enzyme with substantial genetic heterogeneity. Several smaller studies have shown that metoprolol pharmacokinetics is influenced by CYP2D6 genotype and metabolizer phenotype. To increase robu...

Descripción completa

Detalles Bibliográficos
Autores principales: Blake, CM, Kharasch, ED, Schwab, M, Nagele, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818912/
https://www.ncbi.nlm.nih.gov/pubmed/23665868
http://dx.doi.org/10.1038/clpt.2013.96

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818912/
https://www.ncbi.nlm.nih.gov/pubmed/23665868
http://dx.doi.org/10.1038/clpt.2013.96

Ejemplares similares